That is very important, due to the fact that the way a protein in the body folds determines if a pharmaceutical will be able to bind to that protein and be effective. To put it simply, we have to understand how these proteins fold if we want a drug to work. Historically, this has actually been an experimental procedure (jeff brown investment prediction). Now, Alpha, Fold can anticipate protein folding with 92. 4% accuracy. That's going to make it much simpler to create drugs that do what they're created to do. This was an advancement nearly nobody saw. But it's going to have profound implications for curing disease. I forecast that Alpha, Fold will be 98% precise by the end of 2021.
And, obviously, there will be a lot of financial investment chances in this space, too. Moving topics It's going to be a great year for bitcoin. I'm bullish on it in 2021 (future report review). That stated, I still believe bitcoin will continue to be unstable. We're close to all-time highs. I wouldn't be shocked if it pulled back perhaps considerably before going greater - angel investor. I have actually been covering bitcoin for a long time now. Among the very first research reports I ever released was on bitcoin. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
However at the time of that initial suggestion, I titled my report "What's the Big Offer With Bitcoin?" That shows you where the discussion was at the time. We were mainly educating readers. But that's not the big question any longer. Now we're seeing institutional money lastly take an interest in bitcoin. Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some little, niche business. Mass, Mutual is a trusted 170-year-old institution. So believe about that. In five years, we went from informing readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake.
Which's a huge reason I'm bullish on it this year. jeff brown latest prediction. Regards, Jeff Brown, Editor, The Bleeding Edge I have a perk forecast 2020 was a record year for IPOs. 552 U.S. business went public the most in more than 20 years. These companies raised an overall of $172 billion. That's an all-time high beating the previous yearly record by 43%. I predict 2021 will be another record year in IPOs. There are many fantastic private business on the edge of hitting the public markets And I've been working on a new way for you to invest even before these business go public.
This opportunity has actually been constructing over the last few years. I can't wait to tell you all about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Event to find out all the information. Go right here to reserve your spot totally free.
Emma Walsh here, managing editor of the Diary. Regular Diary readers understand that tech isn't our normal beat (jeff brown prediction for 2021). And when it comes to tech investing, we leave it to the professionals. Luckily, we have a number of such professionals in our Rolodex. Our colleague Jeff Brown will be familiar to our long time readers. He is among the most accomplished tech investing specialists we understand (jeff brown top biotech stock 2021). In truth, he had a number of triple-digit returns in his Brownstone Research study portfolios in 2015. Here's what Jeff believes the tech sector will bring us in 2021 Each year, I like to have a look at the huge picture and forecast what's just around the corner.
That includes things like 5G networks, biotech, expert system, and far more. These patterns are experiencing exponential growth and developing incredible opportunities for investors. I wish to make certain all our readers are gotten ready for what's next. And with that in mind, let me draw the picture of what I see can be found in the next 12 months Our brand-new 5G (fifth-generation) wireless networks are a subject I've been covering for years now. democratic republic. But in spite of what many readers may think, this is a pattern that's simply beginning. Although the COVID-19 pandemic interfered with supply chains last year, an outstanding 250 million 5G-enabled devices were still sold.
And all of this eventually resulted in Apple delaying the release of the 5G-enabled i, Phone 12 by two months (what is the legacy report predicting). Losing 2 months of production and sales really impacts how many 5G gadgets are offered in the fiscal year. When you consider all of that, selling 250 million systems is amazing. More significantly, the hold-ups triggered by the pandemic developed a lots of pent-up demand. Which demand is now going to be pressed into 2021. In reality, I anticipate that more than 500 million 5G devices will be delivered in 2021 - united states. And that's not my only 5G prediction When I have actually spoken about 5G in the past, I have actually described its three various phases.
In Stage 2, 5G devices go on sale. 5G phones and other items begin to reach consumers. And in Stage Three, 5G services begin to be provided (jeff brown predictions 2021). That's when we start to see applications running on 5G networks. Believe of things like huge multiplayer games over a smart phone. That's not possible with 4G. It will be with 5G. And my second 5G prediction for 2021 is that we will begin Phase 3 by this summer. This begins something of a virtuous cycle: The majority of people don't really care about the innovation. But they will care if there are amazing applications that can just be accessed with a 5G phone.
That results in more 5G apps being developed. In truth, 5G is going to open up a suite of incredible applications: self-driving cars and trucks, the Web of Things, robotic surgery, and more. All of these innovations need 5G. The investment chances going forward will be enormous. Stepping away from 5G, the next important technology I anticipate in 2021 is CRISPR genetic editing. CRISPR represents "clustered frequently interspaced short palindromic repeat." It's a mouthful. However it is among the most amazing developments in biotechnology. At a high level, CRISPR is a technology that can edit our genetic makeup as if it were software application.
The program can crash or not work properly. CRISPR uses a similar idea but with our genetic code. "Typos" in our genome can cause disease. CRISPR can correct these "typos." For many years, CRISPR was primarily a specific niche technology that wasn't well understood. And during that time, there were really just three companies running in this space. However things are changing. CRISPR is no longer just theoretical. We're seeing real outcomes. We're dealing with illness and seeing that this innovation just works. And as an outcome, a "second crop" of early-stage CRISPR companies is going public and delivering incredible returns. This entire market is efficiently a greenfield chance.
There's room for numerous companies to exist in this area. jeff brown prediction for 2021. And there will be more. That's my forecast for CRISPR in 2021. I predict that two or 3 more hereditary editing business will hold their IPOs. Sticking with biotechnology, we are seeing fantastic things occurring at the merging of biotech and expert system (AI). Google's AI subsidiary, Deep, Mind, just revealed at the end of 2020 that its newest Alpha, Fold software can accurately anticipate the folding of a protein based entirely on its amino acid series with 92. 4% precision. That is very important due to the fact that the method a protein in the human body folds identifies if a pharmaceutical will be able to bind to that protein and work.
Historically, this has been a trial-and-error process. Now, Alpha, Fold can anticipate protein folding with 92. 4% accuracy. That's going to make it a lot easier to develop drugs that do what they're designed to do. And here's my next forecast. I anticipate that Alpha, Fold will be 98% precise by the end of 2021. And we will see not just one however numerous drug treatments produced utilizing this technology. This was among those advancements that nearly no one noticed. However it's going to have profound ramifications for curing disease. And, naturally, there will be a lot of financial investment opportunities in this space, too.
It's going to be a great year for bitcoin. I'm bullish on it in 2021. That stated, I still believe bitcoin will continue to be unpredictable. We're close to all-time highs. I wouldn't be surprised if it drew back perhaps substantially before going greater. I've been covering bitcoin for a very long time now. One of the first research reports I ever released was on bitcoin - jeff brown genetic sequencing stock. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ roi for anyone who followed my suggestion. However at the time of that initial suggestion, I titled my report, "What's the Big Deal With Bitcoin?" That shows you where the conversation was at the time.
However no one is asking that question any longer. Now, we're seeing institutional money finally taking an interest in bitcoin. The huge news was that Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some small, specific niche business. jeff brown genome sequencing. Mass, Mutual is a 150-year-old organization. So think about that. In five years, we went from informing readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. And that's a huge reason why I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have one more benefit forecast In 2021, we're going to have another record year in IPOs. One website reports that Jeff Brown deserves about $27. 5 million and declares the details is up to date since February 2021, but we could not individually validate this claim. Provided Jeff Brown's past, he likely has a considerable net worth, but we can't hammer down an accurate figure at this moment. Brown is best known for his sage-like ability to pick winning innovation stocks. He invested more than 25 years investigating innovation companies like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's substantial experience offers him an outstanding perspective on the market. He's constantly on the hunt for brand-new chances, and he shares a number of his finest choices in the Near Future Report.
That's high praise, but it's not ridiculously reasoned. Brown has an excellent credibility as a stock-picker, and he successfully predicted a few of the greatest financial events of the past 20 years. Although he does not appear to release his picks to the general public, the service's success is a direct indicator of Brown's stock-picking expertise. Nobody on Wall Street gets it ideal whenever, but Jeff Brown's precise forecasts have actually made him legions of dedicated fans. That says a lot about his ability. The Future Report is published by Brownstone Research, a popular financial research publisher. Brownstone Research provides a number of research study services with a wide range of expertises - the legacy report predictions.
The company is also affiliated with Bonner & Partners, another well-respected research study publisher - korean actress. On its site, Brownstone states its mission is to provide retail investors with professional-grade research study: "For too long, the best financial investment research has not been readily available to specific financiers. It has actually been usually booked for investment banks, hedge funds, personal equity, and high-net-worth clients. tech stocks. The mission of Brownstone Research study is to make that sort of proprietary research study offered to any investors seeking to gain an edge in the marketplaces. The goal is simple to provide unique and rewarding financial investment research study found nowhere else." -Brownstone Research website excerpt from the Jeff Brown is the founder of Brownstone Research study, and he likewise functions as the company's Chief Investment Analyst.
With Brown directing the ship, Brownstone Research is a powerhouse publisher with lots to use its clients. After years of consistent success at the helm of top-tier business like Tesla and Space, X, Elon Musk is a family name throughout many of America. If you understand even a little bit about the market, you understand that he has a credibility as a King Midas of sorts. artificial intelligence. Everything he touches relies on gold! Jeff is aware of Elon Musk's executive prowess, so he always has an eye out for the Silicon Valley rock star's next move. This time, Jeff has an early lead on Elon's next huge project.
In reality, Brown thinks S.A.V. tech stocks. might be "the most significant pattern of the 2020s, and he's not alone. Take a look at these quotes from other popular S.A.V. bulls: Elon's next big act will be weding two cutting-edge technologies: expert system and electrical vehicles. Musk hopes the combination will assist him establish the very first fully-autonomous, self-driving cars ever. It's nothing brief of the automobile market's Holy Grail. As you understand, electric automobiles and self-driving vehicle stocks have actually been big this year, however the Wall Street machine has been big on hype without much concrete result. Regardless of a drastic boost in competitors over the past few years, Brown still thinks Musk has the finest opportunity of putting it all together.
tech might be the magic string that ties it all together. S.A.V. stands for Shared Autonomous Vehicle, and it could be the future of transportation. Generally, this innovation would enable you to lease your vehicle as an autonomous, self-driving taxi when you're not using it. You just get out of the cars and truck and press a button on an app that informs the vehicle to "sign up with the fleet." Next thing you know, you're unwinding on your couch while your cars and truck shuttles ride-sharers around town. Most importantly, you get to keep a substantial piece of the earnings. It sounds crazy, but it might be closed than you think.